Short answer
TriSalus Life Sciences, Inc. (TLSI) filed an 8-K current report with the SEC on August 6, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Q2 2026 financial results released for quarter ended June 30, 2026.
TriSalus Life Sciences, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results released for quarter ended June 30, 2026
- Full operating metrics and management commentary contained in Exhibit 99.1
- Exhibit 99.1 furnished under Item 2.02, limiting Section 18 Exchange Act liability absent specific incorporation reference
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TriSalus Life Sciences, Inc. 8-K filings
Get the next TLSI 8-K as it lands
Follow TLSI for push alerts, or ask the research agent what this filing means.